Skip to main content
MYUNGMOON PHARM CO.,LTD logo

MYUNGMOON PHARM CO.,LTD — Investor Relations & Filings

Ticker · 017180 ISIN · KR7017180001 KO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2021-03-19 Audit Report / Informat…
Country KR South Korea
Listing KO 017180

About MYUNGMOON PHARM CO.,LTD

http://mmpharm.co.kr/en/main/

Myungmoon Pharm Co., Ltd. is a research-based pharmaceutical company engaged in the development, manufacturing, and commercialization of healthcare products. The company produces over 250 specialized and general medicines, holding more than 400 manufacturing licenses. Its portfolio includes both ethical (ETC) and over-the-counter (OTC) drugs, with key product areas in anesthetics, digestive agents, and antitussives. The company's operations encompass the wholesale, import, and export of its pharmaceutical products for domestic and international markets.

Recent filings

Filing Released Lang Actions
[기재정정]감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding the submission of an Audit Report (감사보고서 제출). It provides key financial data, audit opinions, and details on the correction of a clerical error in the fiscal period dates. Since it is an official announcement of the audit report submission and contains the summary financial results rather than the full, multi-page audit report document itself, it is classified as a Regulatory Filing (RNS). FY 2020
2021-03-19 Korean
사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for Myungmoon Pharm Co., Ltd. for the fiscal year 2020. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. As it contains full financial statements and audit opinions for a full fiscal year, it is classified as an Annual Report (10-K). FY 2020
2021-03-19 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains detailed information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures, and financial statements for the shareholders. This document is a formal proxy solicitation material sent to shareholders to request their votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2021-03-16 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Myungmoon Pharm) regarding a correction to a previously filed 'Change in Sales or Profit/Loss Structure' report. This type of filing is a standard regulatory disclosure required by the Korea Exchange (KRX) when financial results deviate significantly from previous estimates or require adjustment due to audit processes. It does not constitute a full annual report (10-K) or an earnings release (ER) in the traditional sense, but rather a specific regulatory update on financial structure changes. Therefore, it falls under the 'Regulatory Filings' (RNS) category. FY 2020
2021-03-15 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) issued by Myungmoon Pharm Co., Ltd. It details the date, location, agenda items (such as approval of financial statements and election of directors/auditors), and instructions for proxy voting and electronic voting. This document is a standard proxy solicitation material sent to shareholders to inform them of an upcoming meeting and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2021-03-12 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea for companies to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It includes details about the meeting, the proxy solicitation process, and financial statements (balance sheet, income statement, etc.) as required by law for such filings. While it contains financial data, it is not an Annual Report (10-K) or an Interim Report (IR), but rather a specific proxy solicitation document. Therefore, it is classified as a Proxy Solicitation & Information Statement (PSI).
2021-03-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.